Easy-to-use blood thinners likely to replace Coumadin
February 07, 2012
For atrial fibrillation patients at risk for stroke
MAYWOOD, Ill. -- Within a few years, a new generation of easy-to-use blood-thinning drugs will likely replace Coumadin for patients with irregular heartbeats who are at risk for stroke, according to a journal article by Loyola University Medical Center physicians.
Unlike Coumadin, the new drugs do not require patients to come in to the clinic on a regular basis to check the dose. Nor do the drugs require extensive dietary restrictions.
First author Sarkis Morales-Vidal, MD, and colleagues describe the new drugs in a review article in the February issue of the journal Expert Reviews. Co-authors are Michael J. Schneck, MD, Murray Flaster, MD, and José Biller, MD. All are in the Department of Neurology, Stroke Program, of Loyola University Chicago Stritch School of Medicine. Biller is department chair.
The new drugs include rivaroxaban (Xarelto®), dabigatran etexilate (Pradaxa®) and apixaban (Eliquis®). They do not share the disadvantages of Coumadin, and may provide equal or superior prevention against clots, Morales and colleagues write.
Atrial fibrillation is the most common form of irregular heartbeat, and a major cause of stroke in the elderly. Electrical signals, which regulate the heartbeat, become erratic. Instead of beating regularly, the upper chambers of the heart quiver. Not all the blood gets pumped out, so clots can form. The clots can migrate to the brain and cause strokes.
More than 3 million Americans have atrial fibrillation, and the number is increasing, due in part to the aging population.
Coumadin's generic name is warfarin. For more than 30 years, the drug had been the only anticoagulant for primary and secondary stroke prevention in patients with atrial fibrillation. But the Food and Drug Administration recently approved dabigatran and rivaroxaban to reduce the risk of stroke and blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. The FDA is considering an application to approve apixaban for the same use.
Coumadin must be carefully monitored. If the dose is too high, a patient could experience excessive bruising and be at higher risk for brain hemorrhages. If the dose is too low, the drug would be ineffective in preventing blood clots. Patients typically must come in at least once a month for a blood test to determine whether the dose needs to be adjusted. Some patients have to come in as often as twice a week.
Coumadin patients also must restrict their diets. For example, they should consume only small amounts of cranberry juice and alcohol and not eat large amounts of foods that are rich in vitamin K, such as spinach, brussels sprouts and green tea.
Disadvantages of the new medications include the limited clinical experience and lack of antidotes, the researchers wrote. The newer drugs are more expensive than Coumadin, but reduce the cost of patient monitoring and blood testing, Morales said.
Dabigatran is an effective alternative to Coumadin for stroke prevention in patients with non-valvular atrial fibrillation. Rivaroxaban is another promising alternative for those patients. Apixaban appears to be better than aspirin for stroke prevention in atrial fibrillation patients who are not candidates for Coumadin therapy, Morales and colleagues wrote.
The authors predict that within the next few years, the new drugs will likely replace Coumadin for long-term anticoagulation in selective patients with non-valvular atrial fibrillation.
Loyola University Health System
Related Atrial Fibrillation Current Events and Atrial Fibrillation News ArticlesAF mortality and morbidity high at 1 year despite good anticoagulant use
Mortality and morbidity of atrial fibrillation (AF) patients remains high at one year despite good use of oral anticoagulants, according to the one year follow up of the Atrial Fibrillation General Pilot Registry.Permanent AF doubles risk of stroke compared to paroxysmal AF
Permanent atrial fibrillation (AF) doubles the risk of stroke compared to paroxysmal AF, according to research in more than 6 000 patients presented at ESC Congress today by Dr Thomas Vanassche from Belgium. Simple awareness campaign in general practice identifies new cases of AF
A simple awareness campaign in general practice identifies new cases of atrial fibrillation (AF), according to research presented at ESC Congress today by Professor Jean-Marc Davy from France.ROCKET AF trial suggests that digoxin increases risk of death in AF patients
Digoxin may increase the risk of death in patients with atrial fibrillation (AF) by approximately 20%, according to results from the ROCKET AF trial presented at ESC Congress today by Dr Manesh Patel, director of interventional cardiology and catheterisation labs at Duke University Health System in Durham, North Carolina, US.Experiencing a-fib while hospitalized for surgery linked with increased risk of stroke
In a study that included 1.7 million patients undergoing inpatient surgery, experiencing atrial fibrillation while hospitalized was associated with an increased long-term risk of ischemic stroke, especially following noncardiac surgery.Delay in correcting a-fib irregular cardiac rhythm linked with increased complications
A delay of 12 hours or longer to correct an abnormal cardiac rhythm from atrial fibrillation was associated with a greater risk of thromboembolic complications such as stroke.Management of anticoagulant-associated intracerebral hemorrhage
The Journal of Neurosurgery is pleased to announce today's publication of a supplement to the August issue entitled "Race Against the Clock: Overcoming Challenges in the Management of Anticoagulant-Associated Intracerebral Hemorrhage."Ablation increases survival for adults with atrial fibrillation
Adults who undergo a minimally invasive technique to treat atrial fibrillation are significantly less likely to die from a heart attack or heart failure, according to a long-term study by the University of Michigan Frankel Cardiovascular Center.Monitoring pulse after stroke may prevent a second stroke
New research suggests that regularly monitoring your pulse after a stroke or the pulse of a loved one who has experienced a stroke may be a simple and effective first step in detecting irregular heartbeat, a major cause of having a second stroke.First evidence for painless atrial fibrillation treatment
The first evidence for a shockless treatment for atrial fibrillation (AF) will be presented today at Frontiers in CardioVascular Biology (FCVB) 2014 in Barcelona, Spain.
More Atrial Fibrillation Current Events and Atrial Fibrillation News Articles
Atrial Fibrillation: What You Need to Know: A Beginner's Guide for Patients and Caregivers (Health Matters)|
by Eternal Spiral Books, http://EternalSpiralBooks.com
++The Fourth Edition, published July 31th, 2014, is now available, with updates on the latest information on atrial fibrillation, including the just-published investigation on dabigatran, (Pradaxa), one of the blood thinning medications (anticoagulants) often prescribed for patients with atrial fibrillation.
Atrial Fibrillation is a particular type of irregular heart beat which can have dangerous consequences to your health if left untreated. People with atrial fibrillation, commonly referred to as AF or AFib, are more prone to blood clots, which can lead to heart attack, stroke or even death.
Fortunately, there are a number of effective treatments available for atrial fibrillation, including several recently approved medications, medical devices, and surgical...
Beat Your A-Fib: The Essential Guide to Finding Your Cure: Written in everyday language for patients with Atrial Fibrillation|
by Steve S Ryan PhD (Author), Patti J Ryan (Contributor)
Beat Your A-Fib: The Essential Guide to Finding Your Cure by Steve S. Ryan, PhD
Atrial Fibrillation (A-Fib) is the most common cardiac arrhythmia (abnormal heart rhythm) seen by physicians. Many patients suffering from Atrial Fibrillation have three strikes against them:
1. Their "quality of life" has deteriorated; they are scared or frightened.
2. Many experience side effects from the common drug therapies or simply do not want to live on medication; a cure for their A-Fib hasn't been discussed.
3. Patient information is often out-of-date, incomplete or biased toward a specific pharmaceutical or treatment; much information about new treatment options is written in the language of scientists and doctors.
The author, Dr. Steve Ryan, PhD, a former A-Fib patient,...
The Magnesium Miracle (Revised and Updated Edition)|
by Carolyn Dean (Author)
REVISED AND UPDATED 2014 EDITION
Magnesium is an essential nutrient, indispensable to your health and well-being. By adding this mineral to your diet, you are guarding against—and helping to alleviate—such threats as heart disease, stroke, osteoporosis, diabetes, depression, arthritis, and asthma. But despite magnesium’s numerous benefits, many Americans remain dangerously deficient. Updated and revised throughout with the latest research, featuring an all-new Introduction, this amazing guide explains the vital role that magnesium plays in your body and life. Inside you will discover
• newly available magnesium supplements that the body absorbs more efficiently
• how calcium can increase the risk of heart disease—and how magnesium can lower it
Clinical Management of Atrial Fibrillation|
by Peter Kowey (Author), Adam Mohmand-Borkowski (Author), James Burke (Author)
Clinical Management of Atrial Fibrillation aims to be an authoritative and thoroughly up-to-date clinical guide to the management of atrial fibrillation (AF), including therapies to restore and maintain normal sinus rhythm, strategies for rate and rhythm control, and appropriate anticoagulation regimens. Acute care of the AF patient is also covered in detail. Pivotal clinical trial data are presented, as well as representative case studies.
Medifocus Guidebook on: Atrial Fibrillation|
by Inc. Medifocus.com (Author)
The Medifocus Guidebook on Atrial Fibrillation is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Atrial Fibrillation, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Atrial Fibrillation, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and...
Atrial Fibrillation: From Bench to Bedside (Contemporary Cardiology)|
by Andrea Natale (Editor), Jose Jalife (Editor)
This important new book presents advancements in the treatment and prevention of Atrial Fibrillation (AF). The reader is provided with the latest information that is critically important in the daily care and for the potential cure of patients with AF. Each chapter deals with a different aspect of AF and each chapter is authored by internationally recognized experts in the evolving field of cardiac electrophysiology. This book is a single source that provides a multi-perspective look at and approach to AF. Because AF is so prevalent and affects all areas of medicine, the information in this book will be useful to all those in the medical field.
How To Stop or Prevent Heart Palpitations|
by Stone Adams
An avid researcher and wellness enthusiast, Nick began studying heart palpitations and their risk factors back in 2002 after suffering a series of personal palpitation attacks. Determined to discover what doctors refused to disclose, Nick embarked on an enlightening journey of discovery. The results are proving to have impact not only on the issue of heart palpitations, but also on many other related health issues. "How To Stop or Prevent Heart Palpitations" looks as though it will be just the first in a series of wellness digests from Nick Walsh.
People all over the world suffer from heart palpitations that are so devastating that they lives are affected immensely. These people visit their doctors, but are told that their hearts are fine. After all of the tests are done,...
Keeping Your Heart in Rhythm: The Seven Natural & Safe Ways to Protect Against Irregular Heartbeats...|
by Stuart Kalb (Author)
Do you suffer from heart palpitations and arrhythmias (and you think you areotherwise healthy), or do you want to prevent clogged arteries and other heartdisease? Perhaps you are one of millions who are saddled with over-prescribedcholesterol, blood pressure, and blood thinning medications. Either way, KeepingYour Heart in Rhythm uncovers many unknown facts about heart ailments andheartbeat irregularities and provides safe, natural, and inexpensive ways for youto control all the above issues.Author Stuart B. Kalb, a healthcare, estate planning, elder law and former trialattorney for over thirty years, dissects complicated medical terminology and, inturn, offers concise and easily comprehendible ways you can:? Conquer heartbeat irregularities ? Eliminate high cholesterol? Lower blood...
Atrial Fibrillation Therapy (Current Cardiovascular Therapy)|
by Gheorghe-Andrei Dan (Editor), Antoni Bayés de Luna (Editor), John Camm (Editor)
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.New guidelines have emerged as a result of new mechanisms for initiation and perpetuation for pharmacotherapy to cure AF and trials with new classes of antithrombotic drugs are ongoing. The treatment of AF is still in its infancy, but recent research is revealing how it can be applied with optimal efficacy. This...
A Simple Guide to Atrial Fibrillation, Treatment and Related Conditions (A Simple Guide to Medical Conditions)|
Ode to Atrial Fibrillation
Atrial Fibrillation is an abnormal irregular heart beat
Lung diseases and hyperthyroidism contributes to it
It is caused by coronary heart disease and other heart condition
Other causes are congenital heart disease and systemic afflictions
Typically there is fast heart beats and sense of palpitations
There may chest pains and difficulty in respiration
There may congestive heart failure and ankle swelling
There are irregular heart beats and fainting
Both atrial chambers are enlarged due to irregular heart conditions
ECG will confirm the presence of atrial fibrillation
Treatment is to prevent the throwing out of blood clots
These blood clots can...